Experience

Davis Polk advised ViewRay, Inc. in a direct registered offering of 8,382,643 shares of ViewRay’s common stock for proceeds to ViewRay of approximately $50 million. ViewRay’s common stock…

Davis Polk advised Auris Medical Holding AG in connection with the SEC-registered offering of $1.5 million of its common shares to Lincoln Park Capital Fund, LLC. The common shares are…

Davis Polk advised the representatives of the underwriters in connection with the $122.4 million public offering of 4,800,000 shares of common stock by Flexion Therapeutics, Inc. The…

Davis Polk advised the representative of the initial purchasers on a Rule 144A/Regulation S offering by Hologic, Inc. of $350 million aggregate principal amount of its 4.375% senior…

Davis Polk advised the underwriters in connection with an initial public offering of 7,500,000 shares of common stock of Deciphera Pharmaceuticals, Inc., at $17.00 per share, for total…

Davis Polk advised Kadmon Holdings, Inc. in connection with an $80.4 million offering of 22,275,000 shares of common stock and warrants to purchase 8,910,000 shares of common stock, which…

Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with a $288 million public offering of common stock by Juno…

Davis Polk advised the representatives of the several underwriters in connection with an SEC-registered offering of $400 million aggregate principal amount of 4.400% senior notes due…

Davis Polk advised the joint book-running managers and representatives of the underwriters on the $172.5 million initial public offering by Zai Lab Limited of 9,583,333 American…

Davis Polk advised the forward purchasers and forward sellers in connection with an at-the-market forward underwriting program for the offer and sale of shares of Class A common stock…